Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

ABSTRACT: SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

PROVIDER: PRJNA929492 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23271000.fastq.gz	Fastqsanger.gz
	SRR23271100.fastq.gz	Fastqsanger.gz
	SRR23271200.fastq.gz	Fastqsanger.gz
	SRR23271300.fastq.gz	Fastqsanger.gz
	SRR23271400.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 516

Similar Datasets

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

Project description:To investigate the role of small nucleolar RNAs in the context of antidepressant response and major depressive disorder

2023-07-11 | GSE224050 | GEO

<i>SNORD90</i> induces glutamatergic signaling following treatment with monoaminergic antidepressants.

Project description: Not available

| S-EPMC10335830 | biostudies-literature

Proteomic analysis of E. coli K-12 MG1655 with the treatment of antidepressants

Project description:Proteomics analyses were conducted to reveal bacterial responses towards antidepressants on translational level.

2023-10-24 | PXD033554 | Pride

Epigenetic effects of antidepressants to neuroprotective genes in neuronal cultured cells

Project description:Antidepressants are widely used for treatment of depression. Imipramine, a typical antidepressant, is recently known to have an effect to restore the expression of brain-derived neurotrophic factor gene, which is decreased in depressed patients, by increasing histone acetylation. However, it is largely unknown whether other antidepressants have similar epigenetic effects to change gene expression. To address this question, we examined the effect of five antidepressants (imipramine, citalopram, duloxetine, amitriptyline, mirtazapine) on expression of genes associated with mental and neurodegenetative disorders. We found that 48-hour treatment with imipramine, citalopram, amitriptyline, mirtazapine, but not duloxetine, caused a large number of differentially expressed genes in primary neocortical neurons in mice. Focused on genes relating to neural protection and neuroplasticity, we discovered that amitriptyline not only enhanced the expression of atf3 and cox2 by increasing histone H3 Lys4 trimethylation (H3K4me3), but also protected neurons against oxygen-glucose deprivation and staurosporine-induced apoptosis. Our study will shed a new insight in understanding of the molecular and epigenetic mechanism of antidepressants. Mouse primary neuronal cultures were used to evaluate 48 hour effects of antidepressants. Briefly, cultured neurons at day in vitro 3 (DIV3) were treated with 5ÂµM imipramine, 10 ÂµM citalopram, 0.1 ÂµM duloxetine, 5 ÂµM amitriptylline, 50 ÂµM mirtazepine. These cultures were harvested after 48 hours (DIV5).

2015-01-30 | E-GEOD-63005 | biostudies-arrayexpress

Epigenetic effects of antidepressants to neuroprotective genes in neuronal cultured cells

2015-01-30 | GSE63005 | GEO

Bacteria proteomics under antidepressants exposure

Project description:This project conducted proteomics on A.baylyi ADP1, E. coli K12 and P. putita KT2440 after treated with a few commonly-prescribed antidepressant (duloxetine, sertraline, fluoxetine, bupropion, escitalopram and agomelatine). The results with help to reveal how those antidepressants can promote the transfer of antibiotic resistance genes in those treated bacteria.

2024-01-26 | PXD028020 | Pride

Gene expression profiling of early-activated targets of antidepressants in glia cells

Project description:The identification of cell-type-specific and early-activated pharmacological targets of antidepressants might help to implement the search for alternative targets to develop drugs with safer side-effect profiles and faster onset of actions. Glia cells are active partners of neurons and blood vessels in supporting a variety of functions such as synaptic communication and blood-brain barrier permeability. Impaired glia cells (astrocytes and microglia cells) characterize postmortem brains of major depressive disorder patients, suggesting that they might be specifically modulated by pharmacological treatments to reverse disease phenotypes. Here, we have treated rat C6 glioma cells, used as a model of astrocytes, with two different classes of antidepressants (desipramine and fluoxetine) and two drugs without antidepressant properties (haloperidol and diazepam) to compare transcriptomes of glia cells after treatment with antidepressants versus drugs without antidepressant properties. To this aim, we used microarrays to detail the global early-activated cell-type-specific gene expression program and identified multiple classes of genes selectively modulated by antidepressants in astrocytes.

2016-11-16 | GSE89873 | GEO

Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior

Project description:Accumulating evidence demonstrates that the gut microbiota affects brain function and behavior, including depressive behavior. Antidepressants are the main drugs used for treatment of depression. We hypothesized that antidepressant treatment could modify gut microbiota which can partially mediate their antidepressant effects. Mice were chronically treated with one of five antidepressants (fluoxetine, escitalopram, venlafaxine, duloxetine or desipramine), and gut microbiota was analyzed, using 16s rRNA gene sequencing. After characterization of differences in the microbiota, chosen bacterial species were supplemented to vehicle and antidepressant-treated mice, and depressive-like behavior was assessed to determine bacterial effects. RNA-seq analysis was performed to determine effects of bacterial treatment in the brain. Antidepressants reduced richness and increased beta diversity of gut bacteria, compared to controls. At the genus level, antidepressants reduced abundances of Ruminococcus, Adlercreutzia, and an unclassified Alphaproteobacteria. To examine implications of the dysregulated bacteria, we chose one of antidepressants (duloxetine) and investigated if its antidepressive effects can be attenuated by simultaneous treatment with Ruminococcus flavefaciens or Adlercreutzia equolifaciens. Supplementation with R. flavefaciens diminished duloxetine-induced decrease in depressive-like behavior, while A. equolifaciens had no such effect. R. flavefaciens treatment induced changes in cortical gene expression, up-regulating genes involved in mitochondrial oxidative phosphorylation, while down-regulating genes involved in neuronal plasticity. Our results demonstrate that various types of antidepressants alter gut microbiota composition, and further implicate a role for R. flavefaciens in alleviating depressive-like behavior.

2019-04-05 | GSE129359 | GEO

Gene expression profiles of glutamatergic neuron progenitors (Neurod6-positive cells)

Project description:Gene expression profiles of glutamatergic neuron progenitors (Neurod6-positive cells)

2012-12-08 | E-MTAB-893 | biostudies-arrayexpress

NAD⁺ Reduction in Glutamatergic Neurons Induces Lipid Catabolism and Neuroinflammation in the Brain Via SARM1

Project description:NAD⁺ Reduction in Glutamatergic Neurons Induces Lipid Catabolism and Neuroinflammation in the Brain Via SARM1

| PRJNA1372715 | ENA